Saturday, October 31, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Oct 31, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
StockCIK 1130598

Traws Pharma, Inc. (TRAW): Insider Trades and Fund Holdings

In the past 12 months, Traws Pharma, Inc. insiders reported 1 open-market purchase worth $998K and no sales.

Loading traw price today from TradingView…

Price today, live from TradingView. Values and changes on this page use our weekly prices (as of Oct 2), so trades line up with filings. Why

1Insider buys, 12 months
$998KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding

TRAW price, with every reported trade

Hover or tap a marker to see who traded that week.

▲ insider buy▼ insider sale● Congress■ fund● planned sale■ 5% stake at prices of Oct 2

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Jul 9, 2026NewsCompany reported: Executive or director change
  2. Apr 16, 2026Insider buy10% owner Orbimed Advisors LLC bought $998,207

Daily chart and analysis

Live daily prices and indicators from TradingView. The chart above uses our weekly prices so trades line up with filings.

Loading traw daily chart from TradingView…
Technical signals
Loading traw technical analysis from TradingView…
Company profile
Loading traw company profile from TradingView…

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Apr 28, 2026.

Recent TRAW insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Apr 28Apr 16Orbimed Advisors LLC10% owner10% owner (ind.)▲ BUY597,7291.67$998K48+99%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 31, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Orbimed Advisors LLC10% owner1$998K0$0Apr 28, 2026

Buybacks and executive pay

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$874K$670Kn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

0
Strongest purchase, 12 months

48 Orbimed Advisors LLC (10% owner), 2026-04-16. What the score means

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →

Sources

  1. Form 4: Orbimed Advisors LLC, purchase · filed 2026-04-28

All 1 Form 4 filings for TRAW are in the table above, each linked to the SEC.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.